TMCnet News
Research and Markets: Rhinovirus Infection - Pipeline Review, H2 2012DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/gw7dxq/rhinovirus) has announced the addition of Global Markets Direct's new report "Rhinovirus Infection - Pipeline Review, H2 2012" to their offering. Global Markets Direct's, 'Rhinovirus Infection - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Rhinovirus Infection, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Rhinovirus Infection. Rhinovirus Infection - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC (News - Alert) filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Scope - A snapshot of the global therapeutic scenario for Rhinovirus Infection. - A review of the Rhinovirus Infection products under development by companies and uniersities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Rhinovirus Infection pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Key Topics Covered:
For more information visit http://www.researchandmarkets.com/research/gw7dxq/rhinovirus Source (News - Alert): Global Markets Direct |
